首页|纳米药物递送技术在克服肺癌耐药性中的应用

纳米药物递送技术在克服肺癌耐药性中的应用

扫码查看
肺癌是严重危害人类健康的恶性肿瘤之一,其死亡率在我国所有恶性肿瘤中位列第一.耐药的发生是导致肺癌患者生存结局不容乐观的重要因素,如何克服肺癌耐药性已成为亟待攻克的难题之一.纳米药物递送技术目前已成为克服肺癌耐药性的一种重要手段.针对肺癌发生耐药的机制,采用纳米药物递送技术可实现药物的联合递送、提高药物递送效率、增强药物靶向性和安全性等,为克服肺癌耐药提供了新思路.本文阐述了肺癌治疗的现状、发生耐药的机制及克服耐药性的策略,介绍了纳米技术在肺癌诊断和治疗过程中的应用,综述了纳米药物递送技术在克服肺癌耐药性应用中的最新研究进展,讨论了纳米药物递送技术的发展前景和目前面临的挑战.
Application of Nano-drug Delivery Technology in Overcoming Drug Resistance in Lung Cancer
Lung cancer is one of the most malignant tumor,representing a significant threat to human health.In China,its mortality rate is the highest among all malignant tumors.The occurrence of drug resistance has resulted in unfavour-able prognosis for patients with lung cancer,and overcoming drug resistance is a significant challenge that needs to be ad-dressed.Nano-drug delivery technology has been an important approach to overcome drug resistance in lung cancer.Targeting to the mechanisms of drug resistance,by enabling the combined delivery of drugs,increasing the efficiency of drug delivery and improving the targeting and safety of drugs,nano-drug delivery technology offers a novel approach to tackling drug resistance in lung cancer.This paper describes the current status of lung cancer treatment,mechanisms of drug resistance,strategies to overcome drug resistance,and the application of nanotechnology in the diagnosis and treatment of lung cancer.In addition,it summarizes the recent research progress on the application of nano-drug delivery technology to overcome drug resistance in lung cancer.Finally,the current prospects and challenges of nano-drug delivery technology are discussed.

Lung neoplasmsNano-drug delivery technologyDrug resistance

鲁迎春、王春语、柳斌

展开 >

610054 成都,电子科技大学医学院

610032 成都,成都中医药大学医学与生命科学学院

610042 成都,四川省肿瘤临床医学研究中心/四川省肿瘤医院·研究所/四川省癌症防治中心/电子科技大学附属肿瘤医院肿瘤内科

肺肿瘤 纳米药物递送技术 耐药

2024

中国肺癌杂志
中国抗癌协会 中国防痨协会 天津医科大学总医院

中国肺癌杂志

CSTPCD北大核心
影响因子:1.397
ISSN:1009-3419
年,卷(期):2024.27(11)